TABLE 3.
Antibiotic resistance of ΔoprM P. aeruginosa K1110 expressing mutant OprM proteinsa
| Strain | Plasmid | OprM derivative | OprM expressionb | MIC (μg/ml) ofc:
|
|||||
|---|---|---|---|---|---|---|---|---|---|
| CAR | CPZ | CIP | NOR | CAM | NOV | ||||
| ML5087 | Wild type | + | 32–64 | 8 | 0.2 | 1 | 64 | 128 | |
| K1110 | − | 0.5 | 1 | 0.1 | 0.5 | 64 | 16 | ||
| K1110 | pVLT31 | − | 1 | 1 | 0.1 | 0.5 | 64 | 16 | |
| pXZL34 | Wild type | ++ | 64 | 8 | 0.2 | 1 | 128 | 128 | |
| pXZL74 | ΔP5-P10 | ++ | 32 | 8 | 0.2 | 0.5 | 128 | 128 | |
| pXZL88 | ΔT28-D37 | ++ | 64 | 8 | 0.1 | 1 | 64 | 128 | |
| pXZL92 | ΔR74-I79 | ++ | 32 | 4 | 0.2 | 1 | 64 | 128 | |
| pXZL57 | ΔS93-G107 | + | 64 | 4 | 0.1 | 1 | 64 | 64 | |
| pXZL137 | ΔA12-R98 | −de | 8–16 | 1 | 0.1 | 0.5 | 64 | 16 | |
| pXZL58 | T106-HA-T107 | ++ | 64 | 4 | 0.2 | 0.5 | 128 | 128 | |
| pXZL75 | ΔE125-R131 | − | 0.5 | 1 | 0.1 | 0.5 | 32 | 16 | |
| pXZL89 | ΔA145-A153 | −e | 1 | 0.5 | 0.05 | 0.125 | 32 | 8 | |
| pXZL90 | ΔG199-A209 | + | 0.5 | 1 | 0.05 | 0.25 | 64 | 16 | |
| pXZL73 | ΔA233-G241 | +/− | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL133 | ΔL257-L264 | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL77 | ΔA278-N286 | +/− | 0.5 | 0.5 | 0.05 | 0.25 | 32 | 16 | |
| pXZL91 | ΔF317-F326 | −e | 0.5 | 0.5 | 0.2 | 0.5 | 64 | 16 | |
| pXZL93 | ΔR341-I349 | − | 0.5 | 0.5 | 0.05 | 0.25 | 32 | 16 | |
| pXZL76 | ΔA445-W450 | −de | 2 | 2 | 0.05 | 0.125 | 32 | 16 | |
| pXZL66 | ΔL446-A468 | −e | 0.5 | 1 | 0.1 | 0.25 | 32 | 16 | |
| pXZL67 | ΔA451-A468 | + | 16 | 2 | 0.05 | 0.5 | 64 | 64 | |
| pXZL146 | C1G | + | 64 | 4 | 0.2 | 1 | 128 | 128 | |
| pXZL86 | S2D | ++ | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL147 | OprF-OprM fusion | + | 64 | 4 | 0.2 | 1 | 128 | 128 | |
| pXZL109 | E125K | + | 64 | 8 | 0.2 | 0.5 | 64 | 128 | |
| pXZL125 | L128R | + | 32 | 8 | 0.2 | 1 | 64 | 64 | |
| pXZL104 | F129A | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL105 | F129Y | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL128 | R131E | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL111 | E279D | ++ | 64 | 8 | 0.2 | 0.5 | 128 | 128 | |
| pXZL108 | E279K | + | 64 | 8 | 0.2 | 1 | 128 | 128 | |
| pXZL126 | A284F | ++ | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL129 | A284Y | ++ | 64 | 8 | 0.2 | 1 | 128 | 128 | |
| pXZL106 | L446V | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL110 | L446Q | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL112 | G448T | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL107 | G448A | + | 64 | 8 | 0.2 | 1 | 64 | 128 | |
| pXZL127 | W450Y | ++ | 64 | 8 | 0.2 | 1 | 64 | 128 | |
The antibiotic susceptibility of the ΔoprM strain K1110 harboring plasmids encoding the indicated OprM derivatives was determined as described in Materials and Methods. Susceptibility of the wild type (with respect to MexAB-OprM) parent strain ML5087 is shown for comparison purposes.
Relative expression (taken from Fig. 2) indicated as ++ (high), + (moderate), +/− (weak), or − (none).
Values in italics represent MICs substantially below that provided by the wild-type OprM protein. CAR, carbenicillin; CPZ, cefoperazone; CIP, ciprofloxacin; NOR, norfloxacin; CAM, chloramphenicol; NOV, novobiocin.
OprM expression was detectable in cells following induction with IPTG.
Weakly expressed in E. coli DH5α.